Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults



Status:Completed
Conditions:HIV / AIDS
Therapuetic Areas:Immunology / Infectious Diseases
Healthy:No
Age Range:Any
Updated:11/18/2012
Start Date:January 2010
End Date:May 2013

Use our guide to learn which trials are right for you!

Oral HPV Shedding and Oral Warts After Initiation of Antiretroviral Therapy


Oral human papillomavirus (HPV) and oral warts are common health concerns for HIV-infected
people. This study will examine the frequency of oral HPV DNA shedding and oral warts in
HIV-infected people who are enrolled in ACTG A5257 and who are beginning treatment with
highly active antiretroviral therapy (HAART).


Oral HPV infection occurs at a higher rate among HIV-infected people than among the general
population. Recent research in the United States and Europe has also found that HIV-infected
people have a higher risk of oral and oropharyngeal squamous cell cancer than HIV-uninfected
people. In one study, it was found that HPV seropositivity was associated with an increased
risk of squamous cell carcinoma of the oropharynx (SCCOP). In addition to SCCOP, another
HPV-related health concern is oral warts, a condition for which there is no effective
treatment. Even after beginning treatment with highly active antiretroviral therapy (HAART),
active HPV replication in the mouth and oropharynx may persist in HIV-infected people,
leading to an increased risk of SCCOP and oral warts. The purpose of this study is to
evaluate the frequency of oral HPV DNA shedding and oral warts in HIV-infected people prior
to HAART initiation and at regular time points after HAART initiation.

ACTG A5257 is a study that is comparing the effectiveness of three non-nucleoside reverse
transcriptase inhibitor (NNRTI)-sparing HAART regimens in treatment-naïve participants. This
study will enroll participants from the ACTG A5257 study. Participants will attend a
baseline study visit at the same time as their ACTG A5257 baseline study visit. At baseline
and at Week 4, 16, 24, and 48 study visits, participants will undergo an examination of
their mouth, throat wash and saliva collection, and behavioral questionnaires. A blood
collection will also occur at Week 24.

Inclusion Criteria:

- Meet inclusion criteria for and be enrolled in ACTG A5257

- Ability and willingness of participant or legal guardian/representative to provide
informed consent

Exclusion Criteria:

- Co-enrollment in A5260s

- Has begun receiving HAART as part of the A5257 study

- Has ever received an HPV vaccine or plans to receive an HPV vaccine in the 6 months
after study entry
We found this trial at
34
sites
Los Angeles, California 90033
13
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Stanford, California 94304
327
mi
from 91732
Stanford, CA
Click here to add this to my saved trials
Atlanta, Georgia 30308
1919
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
Baltimore, Maryland 21201
2301
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
Birmingham, Alabama 35294
1784
mi
from 91732
Birmingham, AL
Click here to add this to my saved trials
2269
mi
from 91732
Boston, MD
Click here to add this to my saved trials
Boston, Massachusetts 02114
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Camden, New Jersey 08103
2377
mi
from 91732
Camden, NJ
Click here to add this to my saved trials
Chapel Hill, North Carolina 27514
2195
mi
from 91732
Chapel Hill, NC
Click here to add this to my saved trials
Chicago, Illinois 60612
1729
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
Chicago, Illinois 60611
1729
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
Cincinnati, Ohio 45267
1878
mi
from 91732
Cincinnati, OH
Click here to add this to my saved trials
Cleveland, Ohio 44109
2032
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
Cleveland, Ohio 44106
2032
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
1960
mi
from 91732
Colombus, OH
Click here to add this to my saved trials
Detroit, Michigan 48202
1966
mi
from 91732
Detroit, MI
Click here to add this to my saved trials
Durham, North Carolina 27710
2202
mi
from 91732
Durham, NC
Click here to add this to my saved trials
Greensboro, North Carolina 27401
2152
mi
from 91732
Greensboro, NC
Click here to add this to my saved trials
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Los Angeles, California 90095
13
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Miami, Florida 33139
2320
mi
from 91732
Miami, FL
Click here to add this to my saved trials
Nashville, Tennessee 37204
1763
mi
from 91732
Nashville, TN
Click here to add this to my saved trials
New York, New York 10011
2432
mi
from 91732
New York, NY
Click here to add this to my saved trials
New York, New York 10032
2435
mi
from 91732
New York, NY
Click here to add this to my saved trials
2423
mi
from 91732
Newark, NJ
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19104
2375
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
Providence, Rhode Island 02906
2562
mi
from 91732
Providence, RI
Click here to add this to my saved trials
2268
mi
from 91732
Richmond, VA
Click here to add this to my saved trials
Rochester, New York 14642
2245
mi
from 91732
Rochester, NY
Click here to add this to my saved trials
Rochester, New York 14607
2245
mi
from 91732
Rochester, NY
Click here to add this to my saved trials
San Diego, California 92103
105
mi
from 91732
San Diego, CA
Click here to add this to my saved trials
355
mi
from 91732
San Francisco, CA
Click here to add this to my saved trials
Seattle, Washington 98104
961
mi
from 91732
Seattle, WA
Click here to add this to my saved trials
St. Louis, Missouri 63110
1573
mi
from 91732
St. Louis, MO
Click here to add this to my saved trials